DOCTRINES : CONCENTRATIONS - ENGAGEMENTS - AUTORISATION - SUBSTITUTION - RETRAIT

Post-clearance modification and waiver of EU merger remedies : When the hardest may be yet to come

I. Introduction 1. Could clearance create more problems than a prohibition for the parties to a concentration ? This is a real question for companies faced with considerable difficulties in implementing the merger remedies that conditioned a clearance. 2. Under the EU Merger Regulation (“EUMR”), [1] where the European Commission considers that a concentration would significantly impede effective competition in the common market, in particular as a result of the creation or strengthening of a dominant position, it must prohibit the transaction, unless the parties submit remedies rendering the concentration compatible with the common market. [2] 3. Remedies are not a rare instance in EU merger control. As of 31 May 2014, approximately 6% of all cases notified to the Commission since

L'accès à cet article est réservé aux abonnés

Déjà abonné ? Identifiez-vous

L’accès à cet article est réservé aux abonnés.

Lire gratuitement un article

Vous pouvez lire cet article gratuitement en vous inscrivant.

 

Version PDF

Auteurs

Citation

Charlotte Breuvart, Etienne Chassaing, Post-clearance modification and waiver of EU merger remedies : When the hardest may be yet to come, septembre 2014, Revue Concurrences N° 3-2014, Art. N° 67619, pp. 54-67

Visites 637

Toutes les revues